Core Viewpoint - Sichuan Qiaoyuan Gas Co., Ltd. has signed an investment cooperation agreement with the Chengdu New Materials Industry Functional Zone Management Committee to establish a special gas production base in Chengdu, with a total planned investment of 302 million yuan [1] Investment Project Summary - The project will be implemented in two phases, with the first phase involving an investment of approximately 152 million yuan, covering an area of about 38 acres, and plans to build production facilities for 20,000 tons/year of electronic-grade carbon dioxide, 20,000 tons/year of medical-grade carbon dioxide, 40,000 tons of industrial-grade carbon dioxide, and a hydrogen recovery and purification unit with a capacity of 1,000 standard cubic meters per hour [1] - The second phase will involve an investment of about 150 million yuan, focusing on the construction of production lines for electronic-grade medical carbon dioxide, electronic-grade ultra-pure ammonia, and storage facilities for high-end electronic chemicals and special gases, along with related supporting facilities [1] Company Background - Qiaoyuan Gas holds the largest full liquid air separation gas production line in Southwest China and has established multiple production bases, including those in Dujiangyan, Wenchuan, Meishan, Jintang, and Deyang, with the Deyang base currently under construction [1] - Additionally, the company operates a production line in Fujian with a capacity of 25,000 standard cubic meters per hour and another with a capacity of 40,000 standard cubic meters per hour [1]

Core Viewpoint - Qiaoyuan Co., Ltd. (301286.SZ) is enhancing its core business competitiveness by investing 302 million yuan to establish a special gas production base, aiming to upgrade medical gas capacity and enter strategic emerging fields such as semiconductor manufacturing and new displays [1][2][3]. Investment and Project Details - The company signed an investment cooperation agreement with the Chengdu New Materials Industry Functional Zone Management Committee to invest 302 million yuan in a special gas production base [2]. - The project will be implemented in two phases: Phase 1 involves an investment of approximately 152 million yuan to build facilities for producing 20,000 tons/year of electronic-grade and medical-grade carbon dioxide, along with hydrogen recovery and purification [2]. - Phase 2 will require about 150 million yuan to establish additional production lines for electronic-grade medical carbon dioxide and ultra-pure ammonia, pending further agreements [2][3]. Market Position and Business Expansion - Qiaoyuan Co., Ltd. is the largest liquid air separation gas supplier in Southwest China, focusing on the production and sales of industrial gas products [1][6]. - The company aims to enhance its market advantage by increasing its medical gas production capacity to meet the growing demand in biopharmaceuticals and high-end medical devices [2][3]. Financial Performance and Projections - The company forecasts a net profit of 100 million to 120 million yuan for the first half of 2025, representing a year-on-year growth of 34.38% to 61.26% [1][7]. - The expected non-recurring gains will impact net profit by approximately 8.7 million yuan [8]. - The growth in performance is attributed to expanded gas business scale, increased production and sales volume, revenue growth, and improved gross margins [8]. Strategic Acquisitions - In January, the company announced plans to acquire a controlling stake in Deyang Hongchen Chemical Co., Ltd. for no more than 200 million yuan, aiming to expand its product offerings in the carbon dioxide sector [3][4]. - However, the acquisition was terminated due to a lack of consensus among the parties involved, with no party bearing liability for the termination [4].